🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to find out if rasagiline improves RLS symptom...
Status
Terminated
Location
Advent Research
Start Date
2010-09
Trial ID
NCT01192503
Treatments Being Tested
The purpose of this survey is to evaluate the long-term safety of Rasagilin...
Status
Completed
Location
Takeda Selected Site
Start Date
2018-11-01
Trial ID
NCT03727139
Treatments Being Tested
End-of-dose fluctuations e. g. wearing-off are defined as a recurrence of m...
Status
Completed
Location
Teva Investigational Sites
Start Date
2014-01
Trial ID
NCT02384512
Treatments Being Tested
The purpose of this study is to determine whether rasagiline is effective i...
Status
Terminated
Location
Department of Neurology and Palliative Care Klinikum der Universität München (Hospital of the University of Munich)
Start Date
2010-01
Trial ID
NCT01187888
Treatments Being Tested
When a patient with Parkinson's disease (PD) is initially treated with L-do...
Status
Completed
Location
Multiple Locations
Start Date
2010-07-14
Trial ID
NCT01155466
This is a study of a new medication for the treatment of cognitive impairme...
Status
Completed
Location
Baltimore VA Medical Center
Start Date
2007-01
Trial ID
NCT00492336
Treatments Being Tested
To evaluate the efficacy of a fixed dose of Azilect® (1 mg/day) vs placebo ...
Status
Completed
Location
Multiple Locations
Start Date
2011-01
Trial ID
NCT01268891
The purpose of this study is to fulfil regulatory requirements for registra...
Status
Completed
Location
CN001
Start Date
2012-05
Trial ID
NCT01652313
Treatments Being Tested
The objective of this study is to evaluate the efficacy, tolerability, and ...
Status
Completed
Location
CN002
Start Date
2011-11
Trial ID
NCT01736891
Treatments Being Tested
Sleep-wake disturbances (SWD) are frequent in Parkinson's disease (PD) and ...
Status
Terminated
Location
University Hospital, Neurology
Start Date
2011-09
Trial ID
NCT01178047
Treatments Being Tested